Expert Consumers has named Qustodio the best parental control app of 2025, citing its powerful cross-platform features, recent innovations, and family-focused tools that support both safety and digital wellbeing. Best Parental Control App — Qustodio: recognized for delivering privacy-conscious, easy-to-use software that empowers families to manage screen time, track location, filter web content, and monitor […]

CTF Life today announced the signing of a Memorandum of Understanding with Gleneagles Hospital Hong Kong ('Gleneagles'), CUHK Medical Centre ('CUHKMC'), and Hong Kong Baptist Hospital ('HKBH') to establish strategic partnerships. In a pioneering move, CTF Life has also become the first insurance company to collaborate with Gleneagles MediCentre in Admiralty to launch an exclusive

(NASDAQ:NFLX), SAN DIEGO, Oct. 27, 2025 (GLOBE NEWSWIRE) — The law firm of Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving Netflix, Inc. (NASDAQ: NFLX). If you have information that could assist in the Netflix investigation or if you are a Netflix investor who suffered a loss

Investigation Launched into Netflix, Inc. (NFLX), Attorneys Encourage Investors and Potential Witnesses to Contact RGRD LLP GlobeNewswire October 27, 2025 SAN DIEGO, Oct. 27, 2025 (GLOBE NEWSWIRE) — The law firm of Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving Netflix, Inc. (NASDAQ: NFLX). If you have

(Other OTC:KBLB),(OTC US:KBLB), ANN ARBOR, Mich., Oct. 27, 2025 (GLOBE NEWSWIRE) — Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), a world leader in spider silk technology*, today announced the promotion of Dr. Xiaoli Zhang to the position of Chief Scientist. This promotion follows a series of groundbreaking scientific achievements under Dr. Zhang's

(NASDAQ:ZBIO), – Obexelimab met primary endpoint with a 95% relative reduction in new gadolinium (Gd)-enhancing T1 lesions compared with placebo, p=0.0009 – WALTHAM, Mass., Oct. 27, 2025 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas,” “Zenas BioPharma” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and

Kraig Biocraft Laboratories Promotes Dr. Xiaoli Zhang to Chief Scientist Following Series of Groundbreaking Scientific Breakthroughs GlobeNewswire October 27, 2025 ANN ARBOR, Mich., Oct. 27, 2025 (GLOBE NEWSWIRE) — Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), a world leader in spider silk technology*, today announced the promotion of Dr. Xiaoli Zhang to

Zenas BioPharma Announces Positive Results from Phase 2 MoonStone Trial of Obexelimab in Relapsing Multiple Sclerosis GlobeNewswire October 27, 2025 – Obexelimab met primary endpoint with a 95% relative reduction in new gadolinium (Gd)-enhancing T1 lesions compared with placebo, p=0.0009 – WALTHAM, Mass., Oct. 27, 2025 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas,” “Zenas BioPharma”

Eminent Gold Corp. (TSXV: EMNT) (OTCQB: EMGDF) (FSE: 7AB) (“Eminent” or the “Company”) is pleased to announce it has expanded its Hot Springs Range Project (“HSRP”) in Humboldt County, Nevada (see Figures 1 and 2 for location) through the staking of a new claim package. With this expansion, HSRP now totals approximately 3,941 hectares. This

The Irvine 1NH well was placed on production on October 14th and is currently producing at a strong initial average flow rate of 752 boe/d over two weeks, with no decline in production and a high oil cut of 82% Expansion of the 2025-2026 drilling program to begin across Johnson, Campbell, and Converse Counties, Wyoming